Table 2.

Per-protocol analysis of chloroquine efficacy to treat P. vivax malaria in the Saharan zone in Mauritania

Outcome	Nouakchott	Atar
Number of enrolled patients	67	61
Exclusion after enrollment, n (%)	3 (4.5)	0
Lost-to-follow-up, n (%)	2 (3.0)	4 (6.6)
Per protocol population, n	62	57
PCR-uncorrected outcome*
Early treatment failure, n (%)	0	0
Late clinical failure (LCF), n (%)	0	0
Late parasitological failure, n (%)	0	0
Adequate clinical and parasitological response, n (%)	62 (100)	57 (100)

*PCR correction was not performed due to 100% efficacy (per protocol population) on day 28.